Solid organ transplantations save lives in patients affected by terminal organ failures and improve quality of life. Renal transplantation increases patient survival over dialysis, and lifesaving transplants are indispensable to treat patients with liver, heart, or lung irreversible diseases. But the World Health Organization has calculated that only 10% of the total organ demand is met at this point in time.
Therefore, it is imperative to increase the numbers of transplantable organs. At the UMCG, we are experts in the development of new surgery and organ preservation techniques and new treatment methods. To increase the amount of suitable organs for transplantation, we improve donor organ quality and preservation methods. And we conduct research into good long-term function after transplantation to improve the quality of life of our patients.
To monitor long-term outcomes after transplantation, to define potentially modifiable risk factors and develop biomarkers, we started TransplantLines, a large prospective cohort study of solid organ transplant recipients.